5-IAI - Wikipedia
5-Iodo-2-aminoindane (5-IAI) is a drug which acts as a releasing agent of serotonin, norepinephrine, and dopamine. [2] It was developed in the 1990s by a team led by David E. Nichols at Purdue University. [3] 5-IAI fully substitutes for MDMA in rodents and is a putative entactogen in humans. [3]
5-Iodo-2-aminoindan (5-IAI): chemistry, pharmacology, and …
2013年3月27日 · In 2011, this compound, a psychoactive derivative of 2-aminoindane, was identified in recreational products sold in the United Kingdom. 5-IAI is a rigid analogue of p-iodoamphetamine producing MDMA-like effects. The aim of this paper is to summarize the clinical, pharmacological, and toxicological information about this new potential drug of abuse.
5-Iodo-2-aminoindan | C9H10IN | CID 131506 - PubChem
5-Iodo-2-aminoindan | C9H10IN | CID 131506 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.
Details for Aminoindanes - United Nations Office on Drugs and Crime
Other aminoindanes sold as NPS include highly potent selective serotonin releasing agents such as MDAI and 5-IAI, and ETAI (N-ethyl-5-trifluoromethyl-2-aminoindane) [4] which is an analogue of fenfluramine, a substance formerly marketed as an appetite suppressant [5, 6, 7].
5-IAI was first synthesized and reported in 1991 to study its pharmacological effects and evaluated for neurotoxicity [2,3] and a recent review on aminoindanes addressed the need for analytical profiles as well as the significant challenges in identifying these new “legal highs” [4].
5-Iodo-2-aminoindan, a nonneurotoxic analogue of p …
A rigid analogue, 5-iodo-2-aminoindan (5-IAI), of the serotonin neurotoxic halogenated amphetamine p-iodoamphetamine (PIA) was pharmacologically evaluated for production of serotonin neurotoxicity.
5-IAI - Wikiwand
5-Iodo-2-aminoindane (5-IAI) is a drug which acts as a releasing agent of serotonin, norepinephrine, and dopamine. [2] It was developed in the 1990s by a team led by David E. Nichols at Purdue University. [3] 5-IAI fully substitutes for MDMA in rodents and is a putative entactogen in humans. [3]
5-IAI (hydrochloride) (CAS 1782044-60-3) - Cayman Chem
5-IAI (hydrochloride): An Analytical Reference Standard. CAS Number: 1782044-60-3. Synonym: 5-iodo-2-Aminoindane. Purity: ≥98%.
5-Iodo-2-aminoindan (5-IAI): chemistry, pharmacology, and …
Semantic Scholar extracted view of "5-Iodo-2-aminoindan (5-IAI): chemistry, pharmacology, and toxicology of a research chemical producing MDMA-like effects." by M. Coppola et al.
5-Iodo-2-aminoindan (5-IAI): chemistry, pharmacology, and …
In 2011, this compound, a psychoactive derivative of 2-aminoindane, was identified in recreational products sold in the United Kingdom. 5-IAI is a rigid analogue of p-iodoamphetamine producing MDMA-like effects. The aim of this paper is to summarize the clinical, pharmacological, and toxicological information about this new potential drug of abuse.